![Eagle Pharmaceuticals Inc](/common/images/company/N_EGRX.png)
Eagle Pharmaceuticals Inc (EGRX)
NASDAQ
The current EGRX market cap is 66.75M. The company's latest EPS is USD 2.7444 and P/E is 1.87.
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 74.14M | 65.9M | 60.7M | 66.31M | 64.65M |
Operating Income | 503k | 9.46M | -2.93M | 11.77M | 10.3M |
Net Income | -9.45M | -7.13M | 8.17M | 5.75M | 5.16M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 213.31M | 195.89M | 187.8M | 171.55M | 316.61M |
Operating Income | 38.56M | 21.82M | 32.95M | 2.77M | 80.96M |
Net Income | 31.9M | 14.31M | 11.99M | -8.63M | 35.64M |
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 381.76M | 386.45M | 406.16M | 414.18M | 404.82M |
Total Liabilities | 143.77M | 154.67M | 172.6M | 171.33M | 152.78M |
Total Equity | 237.98M | 231.78M | 233.56M | 242.85M | 252.04M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 238.6M | 254.55M | 253.19M | 253.73M | 406.16M |
Total Liabilities | 77.84M | 75.38M | 67.18M | 77.28M | 172.6M |
Total Equity | 160.76M | 179.17M | 186.01M | 176.45M | 233.56M |
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 26.38M | 13.14M | 50.7M | -33.51M | -33.64M |
Investing | -75.58M | -86.82M | -86.83M | -12.56M | -12.56M |
Financing | -11.89M | -8.6M | 13.79M | 12.65M | 6.24M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 52.38M | 55.99M | 49.5M | 28.22M | 50.7M |
Investing | -133k | -777k | -18.25M | -5.32M | -86.83M |
Financing | -88.12M | -24.23M | -37.87M | -28.39M | 13.79M |
Market Cap | 66.75M |
Price to Earnings Ratio | 1.87 |
Price to Sales Ratio | 0.21 |
Price to Cash Ratio | 1.2 |
Price to Book Ratio | 0.28 |
Dividend Yield | - |
Shares Outstanding | 12.99M |
Average Volume (1 week) | 92.01k |
Average Volume (1 Month) | 87.73k |
52 Week Change | -69.64% |
52 Week High | 18.16 |
52 Week Low | 3.2101 |
Spread (Intraday) | 1.37 (25.28%) |
Company Name | Eagle Pharmaceuticals Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.eagleus.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.